Clustering data with hclust algorithm for Effects of LGG on current drinkers gut metabolism (Study ST000321)

Reversed phase POSITIVE ION MODE (Analysis AN000510)
MetaboliteStructureF1F2F3F4
SM (d42:1)ME1142130.791.390.771.61
SM (d42:2)ME1142140.731.290.731.91
SM (d41:1)ME1142120.950.950.841.92
LPC (20:4)ME1141380.800.971.071.44
SM (d40:1)ME1142110.881.030.861.56
PC (42:7)ME1141781.07NA0.93NA
PC (p-44:4) or PC (o-44:5)ME1141971.02NA0.98NA
PE (p-40:5) or PE (o-40:6)ME1142041.080.590.98NA
PC (p-40:5) or PC (o-40:6)ME1141921.140.571.080.45
PC (p-42:3) or PC (o-42:4)ME1141941.230.621.060.46
CE (18:2)ME1141191.150.741.030.56
Ceramide (d42:2)ME1141221.200.681.090.66
PC (42:5)ME1141771.330.281.060.34
PC (p-40:3) or PC (o-40:4)ME1141901.310.471.150.35
LPC (16:0)ME1141321.070.201.820.19
LPC (o-16:0)ME1141390.960.241.550.23
LPC (16:1)ME1141330.790.191.450.32
LPC (p-18:0) or LPC (o-18:1)ME1141400.840.111.350.23
PE (p-36:4) or PE (o-36:5)ME1142011.400.051.350.02
PE (p-38:4) or PE (o-38:5)ME1142021.560.071.490.04
DG (38:5)ME1141291.26NA0.990.38
TG (42:1)ME1142150.89NA1.190.46
DG (38:6)ME1141301.00NA1.150.48
LPC (20:1)ME1141370.96NA1.100.39
PC (30:1)ME1141421.09NA1.080.51
PC (p-38:2) or PC (o-38:3)ME1141861.00NA1.140.59
PC (p-40:4) or PC (o-40:5)ME1141910.98NA1.050.75
PC (p-42:5) or PC (o-42:6)ME1141961.10NA0.960.62
PC (36:1)ME1141591.330.141.390.49
PC (33:2)ME1141491.280.101.440.53
PC (34:1)ME1141511.270.131.430.53
PC (33:1)ME1141481.250.041.440.60
PC (35:1)ME1141551.260.131.360.65
TG (48:0)_2ME1142191.310.101.350.61
Acylcarnitine C16:0ME1141161.160.251.470.56
Acylcarnitine C18:0ME1141171.190.221.350.50
PC (34:0)ME1141501.300.331.390.41
PC (p-38:3) or PC (o-38:4)ME1141871.300.211.390.38
PC (34:2)ME1141521.290.231.430.44
PC (32:0)ME1141441.270.281.420.45
PC (36:2)ME1141601.270.261.420.45
PC (37:4)ME1141661.320.271.250.44
PC (38:4)ME1141691.380.311.330.39
LPC (18:0)ME1141341.270.141.670.17
PC (30:0)ME1141411.300.141.560.28
LPC (18:1)ME1141351.180.181.590.29
PC (31:0)ME1141431.220.131.620.32
PC (p-36:3) or PC (o-36:4)ME1141851.330.101.430.18
PC (p-38:4) or PC (o-38:5)ME1141881.370.081.380.23
PC (32:1)ME1141451.400.071.420.39
PC (p-34:1) or PC (o-34:2)ME1141821.320.101.470.30
PC (34:3)ME1141531.310.141.490.37
SM (d34:1)ME1142081.290.191.470.39
PC (35:2)ME1141561.360.131.470.34
PC (p-34:0) or PC (o-34:1)ME1141811.340.141.440.39
PC (36:4)ME1141621.410.151.440.28
PC (38:3)ME1141681.390.181.400.36
PE (34:2)ME1141981.440.061.240.60
PE (p-38:5) or PE (o-38:6)ME1142031.460.121.210.17
PC (32:2)ME1141461.370.121.320.45
PC (38:2)ME1141671.410.161.230.42
PC (38:6)ME1141711.400.211.200.45
SM (d34:0)ME1142071.430.261.290.30
PC (36:3)ME1141611.490.191.340.29
PC (38:5)ME1141701.510.221.290.31
DG (36:3)ME1141271.540.221.190.43
DG (36:4)ME1141281.530.281.220.35
TG (48:0)_1ME1142181.050.371.530.56
Acylcarnitine C18:1ME1141181.000.281.440.69
PC (33:0)ME1141471.030.221.290.67
PE (38:4)ME1142001.370.381.070.74
TG (50:0)ME1142251.440.341.030.73
PC (34:4)ME1141541.180.251.070.52
PC (35:4)ME1141581.140.191.180.59
PC (40:4)ME1141721.180.171.120.66
PC (p-36:1) or PC (o-36:2)ME1141831.210.181.280.72
PC (35:3)ME1141571.270.131.250.72
PC (40:5)ME1141731.290.161.220.69
SM (d33:1)ME1142061.140.311.260.77
PC (40:7)ME1141751.310.301.150.65
PC (p-36:2) or PC (o-36:3)ME1141841.270.271.310.61
PC (37:2)ME1141641.220.321.210.70
PC (40:6)ME1141741.220.301.250.66
PC (37:3)ME1141651.230.301.260.69
PE (36:1)ME1141991.250.301.270.68
Ceramide (d42:1)_2ME1141210.991.111.120.65
LPC (18:2)ME1141360.960.671.260.88
PC (36:5)ME1141631.010.970.971.03
TG (52:0)ME1142341.110.831.070.83
PC (p-40:6) or PC (o-40:7)ME1141931.040.911.000.91
SM (d32:1)ME1142051.030.831.080.92
TG (44:1)ME1142161.240.820.781.24
DG (36:1)ME1141251.140.450.990.84
DG (40:7)ME1141311.180.510.951.24
PC (p-42:4) or PC (o-42:5)ME1141951.060.620.971.18
Ceramide (d42:1)_1ME1141200.980.601.111.07
SM (d34:2)ME1142090.920.631.131.10
PC (40:8)ME1141761.080.531.021.03
SM (d36:1)ME1142101.110.391.121.11
PC (p-32:0) or PC (o-32:1)ME1141801.110.200.881.54
TG (49:0)ME1142221.010.421.041.41
PC (o-34:0)ME1141791.000.331.111.26
PC (p-38:5) or PC (o-38:6)ME1141890.970.291.181.36
TG (54:8)ME1142511.381.020.820.64
TG (58:3)ME1142591.330.760.800.94
TG (56:1)ME1142521.360.760.830.85
TG (58:2)ME1142581.390.750.790.83
TG (54:1)ME1142441.460.630.720.96
TG (56:2)ME1142531.540.670.750.74
TG (58:4)ME1142601.490.700.730.80
TG (58:1)ME1142571.390.780.920.68
TG (60:2)ME1142611.460.800.870.65
TG (54:7)ME1142501.520.740.920.53
TG (54:5)ME1142481.540.610.910.59
TG (54:6)ME1142491.570.640.920.50
DG (36:2)ME1141261.670.241.070.39
DG (34:1)ME1141231.690.200.950.58
DG (34:2)ME1141241.540.251.080.57
TG (52:6)ME1142401.700.570.530.93
TG (52:5)ME1142391.740.520.760.57
TG (56:5)ME1142561.640.350.840.66
TG (52:4)ME1142381.590.510.890.61
TG (54:4)ME1142471.600.510.820.68
TG (56:3)ME1142541.840.320.620.72
TG (52:1)ME1142351.780.360.580.88
TG (54:2)ME1142451.830.440.570.78
TG (56:4)ME1142551.740.280.690.81
TG (52:2)ME1142361.700.340.690.86
TG (53:4)ME1142431.670.370.680.87
TG (51:4)ME1142331.580.430.720.89
TG (54:3)ME1142461.650.460.720.80
TG (46:0)ME1142171.570.320.860.80
TG (52:3)ME1142371.590.380.800.83
TG (50:1)ME1142261.660.180.780.88
TG (50:2)ME1142271.640.260.810.82
TG (50:3)ME1142282.190.090.350.81
TG (48:1)ME1142201.950.210.480.89
TG (48:2)ME1142212.100.190.310.92
TG (50:4)ME1142292.010.180.351.01
TG (53:2)ME1142411.420.360.671.42
TG (51:1)ME1142301.600.240.520.99
TG (49:2)ME1142241.560.290.551.34
TG (49:1)ME1142231.580.300.591.16
TG (51:3)ME1142321.760.240.491.21
TG (51:2)ME1142311.700.260.511.27
TG (53:3)ME1142421.680.270.541.23

Factors:

F1Treatment:Alcoholic cirrhosis infusion
F2Treatment:Germ Free Control
F3Treatment:LGG Treated
F4Treatment:Normal Human Infusion
Data matrix
  logo